Invention Grant
US07807393B2 Biomarkers for prostate cancer 有权
前列腺癌生物标志物

Biomarkers for prostate cancer
Abstract:
The present invention relates to compositions and methods for the detecting, treating, and empirically investigating the prostate. In particular, the present invention provides compositions and methods for using neuroligin biomarkers (e.g., NLGN-4Y) in the diagnosis, treatment, and empirical investigation of prostate disorders (e.g., prostate cancer, benign prostatic hypertrophy).
Public/Granted literature
Information query
Patent Agency Ranking
0/0